Applied Biomolecular Technologies

Applied Biomolecular Technologies

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $6.5M

Overview

Applied Biomolecular Technologies is a specialized contract development and commercialization services firm for the biologics and diagnostics sectors. Leveraging a highly credentialed team of PhD scientists, ABT offers a full suite of services from problem identification and technology development to IP strategy and commercialization pathway definition. Its business model is centered on being a collaborative, outsourced partner for companies seeking to commercialize protein-based therapeutics and diagnostics, operating primarily in a pre-revenue or project-based revenue stage as a private entity.

ProteomicsBiologicsAntibodies

Technology Platform

Integrated service model leveraging deep expertise in protein biochemistry, genetic engineering, and commercialization strategy to act as a virtual development team for clients.

Funding History

3
Total raised:$6.5M
Seed$3M
Seed$3M
Grant$500K

Opportunities

The expanding global biologics and complex diagnostics market drives sustained demand for high-end contract development services.
ABT's niche as a premium, collaborative partner for challenging biomolecular problems positions it well against larger, less specialized CROs.

Risk Factors

Revenue is project-based and client-dependent, leading to potential volatility and concentration risk.
High competition in the CRO market and the challenge of retaining top PhD talent in a costly biotech hub like San Diego are significant pressures.

Competitive Landscape

ABT competes in the contract research and development (CRD) space, facing competition from large global CROs (e.g., LabCorp, IQVIA), niche technical specialists, and the in-house teams of potential clients. Its differentiation is a high-touch, collaborative model with deep PhD-level expertise in protein science.